Prime Medicine (PRME) Financials: Revenue & Earnings
PRME$5.25+0.90 +20.57%
$951.32M
Market Cap
—
P/E
—
Forward P/E
—
Score
Prime Medicine (PRME) Financials: Revenue & Earnings
PRME price $5.25 +0.90 +20.57%
- Ticker
- PRME
- Price
- $5.25
- Change
- +0.90 +20.57%
- Market cap ?
- $951.32M
- Beta ?
- 2.38
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
PRME fair value Not meaningful. Price $5.25.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-06 | — | -0.24 | — | 1.33M |
| 2026-08-06 | -0.24 | -0.26 | 1.15M | 2.25M |
| 2026-05-07 | -0.28 | -0.24 | 856.00K | 2.33M |
| 2026-03-03 | -0.22 | -0.25 | 842.00K | 1.29M |
| 2025-11-07 | -0.32 | -0.28 | 1.23M | 2.05M |
| 2025-08-07 | -0.41 | -0.36 | 1.11M | 2.80M |
| 2025-05-08 | -0.40 | -0.32 | 1.45M | 2.33M |
| 2025-02-28 | -0.31 | -0.37 | 2.18M | 6.78M |
| 2024-11-12 | -0.44 | -0.43 | 209.00K | 7.09M |
| 2024-08-08 | -0.46 | -0.40 | 37.77M | 1.63M |
| 2024-05-10 | -0.44 | -0.45 | 591.00K | 1.92M |
| 2024-03-01 | -0.56 | -0.48 | — | 5.71M |
| 2023-11-03 | -0.55 | -0.45 | — | 1.67M |
| 2023-08-07 | -0.47 | -0.42 | — | — |
| 2023-05-11 | -0.44 | -0.42 | — | — |
| 2023-03-09 | -0.56 | -0.65 | — | — |
| 2022-11-14 | -1.54 | -0.71 | — | — |
| 2022-06-30 | -0.50 | — | — | — |
| 2022-03-31 | -0.42 | — | — | — |
| 2021-12-31 | -0.86 | — | — | — |
| 2021-09-30 | -0.32 | — | — | — |
| 2021-06-30 | 0.05 | — | 9.13M | — |
| 2021-03-31 | -11.82 | — | — | — |
| 2021-01-01 | -0.04 | — | — | — |
| 2019-12-31 | -0.04 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency Quarterly.
Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2018-03-22 | $0.01 | — | 2018-03-29 | Quarterly |
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Schenkein David P | Buy | 75.00K | $3.06 | 229.50K |
| 2026-06-05 | Marrazzo Jeffrey D | Buy | 75.00K | $3.06 | 229.50K |
| 2026-06-05 | NELSEN ROBERT | Buy | 75.00K | $3.06 | 229.50K |
| 2026-06-05 | Kelly Michael Aaron | Buy | 75.00K | $3.06 | 229.50K |
| 2026-06-05 | Foster-Cheek Kaye I | Buy | 75.00K | $3.06 | 229.50K |
| 2026-06-05 | Chung Wendy | Buy | 75.00K | $3.06 | 229.50K |
| 2026-06-05 | Cahill Thomas | Buy | 75.00K | $3.06 | 229.50K |
| 2026-04-16 | Makhni Svetlana Ni | Buy | 800.00K | $3.67 | 2.94M |
| 2026-04-16 | Makhni Svetlana Ni | Other | 0 | — | — |
| 2026-02-26 | Reine Allan | Buy | 1.30M | $4.38 | 5.69M |
| 2026-02-23 | LEE ANN L. | Buy | 375.00K | $3.34 | 1.25M |
| 2026-02-23 | Alenson Carman | Buy | 140.00K | $3.34 | 467.60K |
| 2025-08-01 | LEE ANN L. | Buy | 181.00K | $4.04 | 731.22K |
| 2025-08-01 | LEE ANN L. | Sell | 181.00K | $12.30 | 2.23M |
| 2025-08-01 | LEE ANN L. | Sell | 181.00K | $8.49 | 1.54M |
| 2025-08-01 | Schenkein David P | Buy | 45.00K | $4.04 | 181.80K |
| 2025-08-01 | Schenkein David P | Buy | 39.06K | $4.04 | 157.81K |
| 2025-08-01 | Schenkein David P | Sell | 45.00K | $7.68 | 345.60K |
| 2025-08-01 | Schenkein David P | Sell | 39.06K | $14.83 | 579.29K |
| 2025-08-01 | NELSEN ROBERT | Buy | 45.00K | $4.04 | 181.80K |
| 2025-08-01 | NELSEN ROBERT | Buy | 39.06K | $4.04 | 157.81K |
| 2025-08-01 | NELSEN ROBERT | Sell | 39.06K | $14.83 | 579.29K |
| 2025-08-01 | NELSEN ROBERT | Sell | 45.00K | $7.68 | 345.60K |
| 2025-08-01 | Marrazzo Jeffrey D | Buy | 250.00K | $4.04 | 1.01M |
| 2025-08-01 | Marrazzo Jeffrey D | Buy | 92.00K | $4.04 | 371.68K |
| 2025-08-01 | Marrazzo Jeffrey D | Buy | 45.00K | $4.04 | 181.80K |
| 2025-08-01 | Marrazzo Jeffrey D | Sell | 250.00K | $8.63 | 2.16M |
| 2025-08-01 | Marrazzo Jeffrey D | Sell | 45.00K | $7.68 | 345.60K |
| 2025-08-01 | Marrazzo Jeffrey D | Sell | 92.00K | $14.04 | 1.29M |
| 2025-08-01 | Kelly Michael Aaron | Buy | 45.00K | $4.04 | 181.80K |
| 2025-08-01 | Kelly Michael Aaron | Buy | 39.06K | $4.04 | 157.81K |
| 2025-08-01 | Kelly Michael Aaron | Buy | 13.51K | $4.04 | 54.58K |
| 2025-08-01 | Kelly Michael Aaron | Buy | 9.01K | $4.04 | 36.38K |
| 2025-08-01 | Kelly Michael Aaron | Sell | 45.00K | $7.68 | 345.60K |
| 2025-08-01 | Kelly Michael Aaron | Sell | 13.51K | $10.54 | 142.40K |
| 2025-08-01 | Kelly Michael Aaron | Sell | 9.01K | $17.00 | 153.10K |
| 2025-08-01 | Kelly Michael Aaron | Sell | 39.06K | $14.83 | 579.29K |
| 2025-08-01 | Foster-Cheek Kaye I | Buy | 45.00K | $4.04 | 181.80K |
| 2025-08-01 | Foster-Cheek Kaye I | Buy | 39.06K | $4.04 | 157.81K |
| 2025-08-01 | Foster-Cheek Kaye I | Buy | 13.51K | $4.04 | 54.58K |
| 2025-08-01 | Foster-Cheek Kaye I | Buy | 9.01K | $4.04 | 36.38K |
| 2025-08-01 | Foster-Cheek Kaye I | Sell | 13.51K | $10.92 | 147.53K |
| 2025-08-01 | Foster-Cheek Kaye I | Sell | 9.01K | $17.00 | 153.10K |
| 2025-08-01 | Foster-Cheek Kaye I | Sell | 39.06K | $14.83 | 579.29K |
| 2025-08-01 | Foster-Cheek Kaye I | Sell | 45.00K | $7.68 | 345.60K |
| 2025-08-01 | Chung Wendy | Buy | 45.00K | $4.04 | 181.80K |
| 2025-08-01 | Chung Wendy | Buy | 39.06K | $4.04 | 157.81K |
| 2025-08-01 | Chung Wendy | Buy | 13.51K | $4.04 | 54.58K |
| 2025-08-01 | Chung Wendy | Buy | 9.01K | $4.04 | 36.38K |
| 2025-08-01 | Chung Wendy | Sell | 13.51K | $10.54 | 142.40K |
| 2025-08-01 | Chung Wendy | Sell | 45.00K | $7.68 | 345.60K |
| 2025-08-01 | Chung Wendy | Sell | 39.06K | $14.83 | 579.29K |
| 2025-08-01 | Chung Wendy | Sell | 9.01K | $17.00 | 153.10K |
| 2025-08-01 | Cahill Thomas | Buy | 45.00K | $4.04 | 181.80K |
| 2025-08-01 | Cahill Thomas | Buy | 39.06K | $4.04 | 157.81K |
| 2025-08-01 | Cahill Thomas | Sell | 39.06K | $14.83 | 579.29K |
| 2025-08-01 | Cahill Thomas | Sell | 45.00K | $7.68 | 345.60K |
| 2025-08-01 | Reine Allan | Buy | 850.00K | $4.04 | 3.43M |
| 2025-08-01 | Reine Allan | Sell | 850.00K | $6.80 | 5.78M |
| 2025-08-01 | Alenson Carman | Buy | 90.50K | $4.04 | 365.61K |
| 2025-08-01 | Alenson Carman | Buy | 16.08K | $4.04 | 64.98K |
| 2025-08-01 | Alenson Carman | Buy | 6.25K | $4.04 | 25.27K |
| 2025-08-01 | Alenson Carman | Sell | 16.08K | $10.92 | 175.63K |
| 2025-08-01 | Alenson Carman | Sell | 90.50K | $8.49 | 768.33K |
| 2025-08-01 | Alenson Carman | Sell | 90.50K | $12.30 | 1.11M |
| 2025-08-01 | Alenson Carman | Sell | 6.25K | $13.63 | 85.24K |
| 2025-08-01 | GV 2021 GP, L.L.C. | Buy | 1.50M | $3.30 | 4.95M |
| 2025-08-01 | NELSEN ROBERT | Buy | 3.03M | $3.30 | 10.00M |
| 2025-08-01 | ARCH Venture Partners XII, LLC | Buy | 3.03M | $3.30 | 10.00M |
| 2025-08-01 | ARCH Venture Partners X, LLC | Buy | 3.03M | $3.30 | 10.00M |
| 2025-06-30 | Liu David R. | Buy | 21.00K | $2.52 | 52.83K |
| 2025-06-23 | Liu David R. | Buy | 21.00K | $2.16 | 45.40K |
| 2025-06-16 | Liu David R. | Buy | 21.00K | $1.49 | 31.20K |
| 2025-06-11 | Liu David R. | Buy | 21.00K | $1.60 | 33.59K |
| 2025-06-04 | Schenkein David P | Buy | 55.00K | $1.32 | 72.60K |
| 2025-06-04 | Marrazzo Jeffrey D | Buy | 55.00K | $1.32 | 72.60K |
| 2025-06-04 | NELSEN ROBERT | Buy | 55.00K | $1.32 | 72.60K |
| 2025-06-04 | Kelly Michael Aaron | Buy | 55.00K | $1.32 | 72.60K |
| 2025-06-04 | Foster-Cheek Kaye I | Buy | 55.00K | $1.32 | 72.60K |
| 2025-06-04 | Chung Wendy | Buy | 55.00K | $1.32 | 72.60K |
| 2025-06-04 | Cahill Thomas | Buy | 55.00K | $1.32 | 72.60K |
| 2025-05-21 | LEE ANN L. | Buy | 100.00K | $1.13 | 113.00K |
| 2025-05-21 | Reine Allan | Buy | 125.00K | $1.18 | 147.15K |
| 2025-05-20 | Brudnick Richard | Buy | 20.00K | $1.19 | 23.79K |
| 2025-05-19 | Marrazzo Jeffrey D | Buy | 800.00K | $1.33 | 1.07M |
| 2025-05-19 | Reine Allan | Buy | 2.00M | $1.33 | 2.67M |
| 2025-05-08 | Reine Allan | Buy | 75.00K | $6.80 | 510.00K |
| 2025-05-08 | Gottesdiener Keith Michael | Buy | 100.00K | $8.32 | 832.00K |
| 2025-05-08 | LEE ANN L. | Buy | 80.42K | $3.67 | 295.13K |
| 2025-02-28 | Gottesdiener Keith Michael | Buy | 500.00K | $2.52 | 1.26M |
| 2025-02-27 | Alenson Carman | Buy | 90.50K | $2.42 | 219.01K |
| 2025-02-27 | Goldwasser Meredith | Buy | 90.50K | $2.42 | 219.01K |
| 2025-02-27 | Duffield Jeremy | Buy | 275.00K | $2.42 | 665.50K |
| 2025-02-27 | LEE ANN L. | Buy | 275.00K | $2.42 | 665.50K |
| 2025-02-27 | Brudnick Richard | Buy | 225.00K | $2.42 | 544.50K |
| 2025-02-27 | Reine Allan | Buy | 275.00K | $2.42 | 665.50K |
| 2024-12-05 | Gottesdiener Keith Michael | Buy | 100.00K | $8.32 | 832.00K |
| 2024-12-05 | Brudnick Richard | Buy | 19.30K | $7.96 | 153.63K |
| 2024-12-05 | Reine Allan | Buy | 75.00K | $6.80 | 510.00K |
| 2024-10-08 | Gottesdiener Keith Michael | Buy | 226.93K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 195, holders -2 vs prior quarter. Ownership 60.75%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| ALPHABET INC. | 16.56M | 0 | 0.00% | 61.12M |
| BLACKROCK, INC. | 9.60M | 1.10M | +12.94% | 35.43M |
| ARK INVESTMENT MANAGEMENT LLC | 8.35M | 2.10M | +33.65% | 30.81M |
| STATE STREET CORP | 7.58M | 1.23M | +19.41% | 27.96M |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 5.24M | -244.56K | -4.46% | 19.33M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.52M | 48.48K | +1.08% | 16.69M |
| BALYASNY ASSET MANAGEMENT L.P. | 3.97M | -154.28K | -3.74% | 14.65M |
| GOLDMAN SACHS GROUP INC | 3.43M | 2.46M | +253.51% | 12.66M |
| CASDIN CAPITAL, LLC | 3.17M | 0 | 0.00% | 11.69M |
| WOODLINE PARTNERS LP | 3.00M | 591 | +0.02% | 11.08M |
| UBS GROUP AG | 2.79M | -93.73K | -3.24% | 10.31M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.71M | -31.25K | -1.14% | 10.01M |
| SUMITOMO MITSUI TRUST GROUP, INC. | 2.41M | -527.81K | -17.95% | 8.90M |
| AMOVA ASSET MANAGEMENT AMERICAS, INC. | 2.41M | -533.77K | -18.15% | 8.86M |
| CITADEL ADVISORS LLC | 2.05M | 1.95M | +1946.36% | 7.58M |
| ADAR1 CAPITAL MANAGEMENT, LLC | 2.00M | 24.27K | +1.23% | 7.37M |
| FMR LLC | 1.76M | -7.59K | -0.43% | 6.50M |
| TWO SIGMA INVESTMENTS, LP | 1.52M | -48.30K | -3.07% | 5.63M |
| REDMILE GROUP, LLC | 1.39M | -201.20K | -12.65% | 5.13M |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 1.24M | 0 | 0.00% | 4.58M |
| JUMP FINANCIAL, LLC | 1.24M | 1.24M | New | 4.58M |
| BANK OF AMERICA CORP /DE/ | 981.34K | 404.33K | +70.07% | 3.62M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 961.83K | 99.62K | +11.55% | 3.55M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 927.54K | 927.54K | New | 3.42M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 927.54K | 10.33K | +1.13% | 3.42M |
Earnings and financials
Prime Medicine, Inc. (PRME) trades at $5.25, with a market cap of $951.32M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn